article thumbnail

U.S. government spent more on health care in 2022 than six countries with universal health care combined

STAT

trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 American taxpayers footed the bill for at least $1.8 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services.

364
364
article thumbnail

Why the biopharma ‘IPO playbook’ changed in 2022

PharmaVoice

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

264
264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The 2022 PharmaVoice 100

PharmaVoice

From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

344
344
article thumbnail

High sensitivity cardiac troponins for ED chest pain evaluation (2022 ACC pathway)

ALiEM - Pharm Pearls

The 2022 American College of Cardiology (ACC) pathway provides timely guidance [1]. Applying the 2022 ACC guideline Before delving into the specifics of the hs-cTn pathways, start with the ECG. The ACC 2022 pathway has a section dedicated to ECGs in ischemia [1], and FOAMcast has a great visual summary.

Hospitals 276
article thumbnail

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $1.2 billion last year, according to a new report.

article thumbnail

STAT+: Moderna CEO made $398 million in 2022, but still pledges to give most to charity

STAT

Bancel made $398 million in 2022 based on the actual realized gains of stock that was exercised and sold, according to STAT’s calculations from Moderna’s annual compensation disclosure filed this week.

Vaccines 263
article thumbnail

STAT+: How Blue Cross Blue Shield insurers ratcheted up profits in 2022

STAT

Publicly traded health insurers were not the only ones in the industry that continued to amass large windfalls in 2022. billion in profit for Health Care Service Corp., the parent of five Blues plans. A quadrupling of profit at BCBS of Alabama.

246
246